Immediate Benefits: Experience quicker results, such as increased energy, improved mood, and enhanced immune function
Phase 2 RCT in The Lancet : at 24 weeks, tesofensine 0.5 mg produced a mean diet-adjusted weight loss of 9.2%, and at 1.0 mg a loss of 10.6%, compared with 2.0% for diet plus placebo (p 99% (HPLC, LCMS) Documentation: Batch-specific Certificate of Analysis (COA) included Handling for Research Use Tesofensine capsules ship as a pre-encapsulated, dry oral-research format
SAG has the ability to penetrate the mitochondrial membrane, helping to maintain its integrity and function
La maggior parte degli utilizzatori somministra una volta al giorno, al mattino o alla sera
HPLC purity assay Mass-spec identity Measured content 10 ml Test date 04/06/2026 Current batch BOH-01/08 Method HPLC LC-MS Certificate of Analysis available Download or independently verify the full third-party report for this peptide
IV therapy is monitored and administered by our independently-licensed Nurse practitioner after review of your health questionnaire